Where do AbCellera Biologics Inc.'s ratios come from?

Every ratio is computed from AbCellera Biologics Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Operating margin	-267.6%+21.4pp	-289%+451pp	-739.7%+108pp	-847.6%+548pp	-1,395.3%-304pp
Net margin	-181.7%+13.1pp	-194.9%+291pp	-486%+17.9pp	-503.9%+222pp	-726.2%-161pp
EBITDA margin	-237.8%+21.8pp	-259.5%+429pp	-688.3%+7.8pp	-696.1%+349pp	-1,045.5%-233pp
Free cash flow margin	-238.9%-7.2pp	-231.7%+202pp	-433.4%-10.7pp	-422.8%+197pp	-619.9%+28.5pp
Returns
Return on equity	-14.7%-0.2pp	-14.5%+2.3pp	-16.8%-1.2pp	-15.6%0.0pp	-15.6%-0.8pp
Return on assets	-10.9%-0.1pp	-10.8%+1.7pp	-12.5%-0.7pp	-11.8%+0.2pp	-12%-0.5pp
Return on invested capital	-22.5%-0.2pp	-22.3%+3.9pp	-26.2%+1.1pp	-27.3%+5.6pp	-32.9%-2.3pp
Efficiency
Asset turnover	0.1×0.0×	0.1×0.0×	0×0.0×	0×0.0×	0×0.0×
Liquidity
Current ratio	14.1×+2.7×	11.3×+1.2×	10.1×-1.0×	11.1×+0.9×	10.1×+0.3×
Quick ratio	13.9×+2.7×	11.2×+1.1×	10.1×-1.0×	11.1×+0.9×	10.1×+0.3×
Cash ratio	2.2×+0.2×	2×+0.4×	1.6×-0.2×	1.8×-0.7×	2.4×+0.4×
Leverage
Debt-to-equity	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×+0.1×	0.1×0.0×
Debt-to-assets	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×+0.1×	0.1×0.0×
Per Share
Book value per share	$3.10-4.4%	$3.24+0.4%	$3.23-4.4%	$3.37-1.8%	$3.44-4.2%
Valuation
Market capitalization	$1.06B+3.4%	$1.02B-31.9%	$1.5B+36.8%	$1.1B+65.3%	$664.51M-23.2%
Enterprise value	$1.1B+5.6%	$1.04B-32.4%	$1.54B+36.9%	$1.12B+105%	$548.09M-29.2%
Price / sales	13.4×-0.3×	13.6×-28.9×	42.6×+9.1×	33.4×+4.7×	28.7×-1.3×
Price / book	1.1×+0.1×	1.1×-0.5×	1.6×+0.5×	1.1×+0.4×	0.6×-0.2×
EV / sales	13.8×0.0×	13.8×-29.7×	43.5×+9.4×	34.2×+10.4×	23.7×-3.1×
Free cash flow yield	-17.9%-0.9pp	-17%-6.8pp	-10.2%+2.5pp	-12.7%+8.9pp	-21.6%0.0pp
Earnings yield	-13.6%+0.7pp	-14.3%-2.9pp	-11.4%+3.7pp	-15.1%+10.2pp	-25.3%-6.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do AbCellera Biologics Inc.'s ratios come from?: Every ratio is computed from AbCellera Biologics Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.